—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for FPH.AU, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sector × region Health care in Asia-Pacific developed: −0.6% week · −3.2% month · −0.7% quarter · −4.5% yearThe Sector Engine cell this name lives in, from 1621.TSE; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against FPH.AU on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Fisher & Paykel Healthcare Corporation Ltd

FPH.AU in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Fisher & Paykel Healthcare designs and sells medical devices for respiratory care, surgery and obstructive sleep apnoea treatment, sold to hospitals and used at home. Its adult and infant respiratory lines cover ventilation support, humidification and nasal high-flow therapy, while its homecare range includes CPAP devices, masks and data-management software. Founded in 1934, it is based in Auckland, New Zealand, and sells into North America, Europe and the Asia Pacific.
Where it sits in the stack
The company sits outside the diary's AI build-out coverage; it belongs to the Healthcare sector within our wider universe, in the Medical Instruments & Supplies industry, and carries no seat in our index.
Who it is priced against
Closelooknet groups it with other scored Healthcare names for comparison — argenx, Eli Lilly, Medpace, BeiGene, UCB, Globus Medical and Regeneron; the market also names ResMed as a direct competitor in respiratory and sleep-therapy devices.
Why Closelooknet tracks it
It carries a Closelooknet score, our multi-module read of a stock; momentum is its strongest module and valuation its weakest. It holds no seat in our index and the diary has not yet quoted it in an edition.
What the diary watches
Whether the valuation module narrows against its stronger momentum reading, and whether growth in home-use respiratory devices keeps pace with the hospital side of the business.

Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) trades on the AU exchange in Australia, classified under Healthcare.

The Closelooknet company score reads 61/100 composite (momentum 78, quality 72, valuation 29) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 1.17%, semi-annual · last 0.27 AUD on 2026-06-22

Dividends and capital return

What FPH.AU pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.44 AUD per share · a 1.17% yield on the 2026-10-06 close 2 distributions, paid twice a year 2026-10-06
  • Change on the year +95.5% against the prior twelve months prior twelve months 0.22 AUD per share
  • Last distribution 0.27 AUD per share as the price series records it, within days of the ex-date 2026-06-22
  • By calendar year 2025: 0.39 AUD (partial) · 2026: 0.27 AUD to date first distribution recorded in the three-year window: 2025-06-23
  • Dividends paid, FY2026 254 m AUD 54% of earnings
  • Share count +0.1% in FY2026
  • Capital returned 254 m AUD · 51% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Fisher & Paykel Healthcare Corporation Ltd (FPH.AU)?

Fisher & Paykel Healthcare Corporation Ltd trades as FPH.AU on the AU exchange (Australia) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is FPH.AU in a Closelooknet index?

Not currently — Fisher & Paykel Healthcare Corporation Ltd is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

What is Fisher & Paykel Healthcare Corporation Ltd's Closelooknet composite score?

61 out of 100, with momentum 78, quality 72 and valuation 29 sub-scores, as of 2026-10-07. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does FPH.AU trade against its moving averages?

Uptrend stack intact: Trades +4.1% vs the 50-day and +14.6% vs the 200-day average, 1.2% below the 52-week high and +42% off the 52-week low; a golden cross printed 49 sessions ago. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Fisher & Paykel Healthcare Corporation Ltd compare with its peers?

Against its peer group (Medical Instruments & Supplies), Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) sits 1.2% below its 52-week high, 4.1% above its 50-day average; Ansell Ltd (ANN.AU) is 0.9% below, Intuitive Surgical Inc (ISRG) is 32.7% below, Ypsomed Holding AG (YPSN.SW) is 12.4% below. Put any of them next to FPH.AU in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does Fisher & Paykel Healthcare Corporation Ltd do?

Fisher & Paykel Healthcare designs and sells medical devices for respiratory care, surgery and obstructive sleep apnoea treatment, sold to hospitals and used at home. Its adult and infant respiratory lines cover ventilation support, humidification and nasal high-flow therapy, while its homecare range includes CPAP devices, masks and data-management software. Founded in 1934, it is based in Auckland, New Zealand, and sells into North America, Europe and the Asia Pacific. Closelooknet groups it with other scored Healthcare names for comparison — argenx, Eli Lilly, Medpace, BeiGene, UCB, Globus Medical and Regeneron; the market also names ResMed as a direct competitor in respiratory and sleep-therapy devices.

Where does Fisher & Paykel Healthcare Corporation Ltd sit in the AI build-out?

The company sits outside the diary's AI build-out coverage; it belongs to the Healthcare sector within our wider universe, in the Medical Instruments & Supplies industry, and carries no seat in our index. It carries a Closelooknet score, our multi-module read of a stock; momentum is its strongest module and valuation its weakest. It holds no seat in our index and the diary has not yet quoted it in an edition.

Does Fisher & Paykel Healthcare Corporation Ltd pay a dividend?

Fisher & Paykel Healthcare Corporation Ltd has paid 0.44 AUD per share over the last twelve months, paid twice a year, a trailing yield of 1.17% on the 2026-10-06 close; the last distribution recorded in the price series was 0.27 AUD on 2026-06-22. In fiscal 2026 the company paid 254 m AUD in dividends, 51% of that year’s free cash flow. The share count rose 0.1% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for FPH.AU, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.